Liquidia Corporation (LQDA)
NASDAQ·Healthcare·Biotechnology
$68.33
+0.47%
Mkt Cap $6.37B
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$50.67
Range $47.00 – $55.00
Implied Upside
-25.8%
Consensus $50.67 vs current $68.33
NASDAQ·Healthcare·Biotechnology
$68.33
+0.47%
Mkt Cap $6.37B
No recent rating data.
Price Target (15 analysts)
$50.67
Range $47.00 – $55.00
-25.8%
Consensus $50.67 vs current $68.33